(DNTL) dentalcorp Holdings - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA24874B1085
DNTL: Dental, Health, Care, Services
Dentalcorp Holdings Ltd. (TO:DNTL) is a leading consolidator and operator of dental practices in Canada, with a proven track record of acquiring and partnering with dental clinics to enhance their operational efficiency and patient care. The company, founded in 2011 and headquartered in Toronto, has established itself as a key player in the Canadian dental care landscape.
From a financial perspective, Dentalcorp operates with a market capitalization of approximately 1.54 billion CAD, reflecting its significant scale and market presence. The company’s forward P/E ratio of 14.68 indicates expectations for future earnings growth, while its P/S ratio of 1.02 suggests that investors are valuing the company based on its revenue generation capabilities. Notably, the P/B ratio of 0.89 signals that the market is valuing the company’s assets at a slight discount relative to book value.
For investors and fund managers, Dentalcorp’s business model is noteworthy for its focus on consolidating a fragmented dental care market. By acquiring and partnering with dental practices, the company is able to achieve economies of scale, standardize care protocols, and invest in advanced technology and training for its network of clinics. This approach not only enhances patient outcomes but also positions the company to benefit from the growing demand for dental care services in Canada.
Additionally, Dentalcorp’s financial structure and operational strategy provide insights into its potential for long-term value creation. The company’s ability to integrate newly acquired practices into its network, coupled with its focus on optimizing clinical and administrative processes, underscores its commitment to sustainable growth and profitability. Investors should consider the company’s ability to maintain its growth trajectory, manage integration risks, and adapt to evolving regulatory and competitive dynamics in the Canadian healthcare sector.
Additional Sources for DNTL Stock
DNTL Stock Overview
Market Cap in USD | 1,095m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
DNTL Stock Ratings
Growth Rating | -38.9 |
Fundamental | 32.8 |
Dividend Rating | 0.0 |
Rel. Strength | 25 |
Analysts | - |
Fair Price Momentum | 6.96 CAD |
Fair Price DCF | 17.12 CAD |
DNTL Dividends
No Dividends PaidDNTL Growth Ratios
Growth Correlation 3m | 19.2% |
Growth Correlation 12m | 17.5% |
Growth Correlation 5y | -70.3% |
CAGR 5y | -13.72% |
CAGR/Max DD 5y | -0.19 |
Sharpe Ratio 12m | 0.78 |
Alpha | 14.87 |
Beta | 0.657 |
Volatility | 33.83% |
Current Volume | 121.9k |
Average Volume 20d | 200k |
As of April 19, 2025, the stock is trading at CAD 7.92 with a total of 121,900 shares traded.
Over the past week, the price has changed by +1.41%, over one month by +6.17%, over three months by +1.41% and over the past year by +24.33%.
Neither. Based on ValueRay Fundamental Analyses, dentalcorp Holdings is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNTL as of April 2025 is 6.96. This means that DNTL is currently overvalued and has a potential downside of -12.12%.
dentalcorp Holdings has no consensus analysts rating.
According to ValueRays Forecast Model, DNTL dentalcorp Holdings will be worth about 7.5 in April 2026. The stock is currently trading at 7.92. This means that the stock has a potential downside of -5.18%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 12.5 | 58.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 7.5 | -5.2% |